Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Rasburicase Therapy in the Context of G6PD Deficiency Genotype

Glucose‐6‐phosphate dehydrogenase (G6PD) deficiency is associated with development of acute hemolytic anemia (AHA) induced by a number of drugs. We provide guidance as to which G6PD genotypes are associated with G6PD deficiency in males and females. Rasburicase is contraindicated in G6PD‐deficient p...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Relling, M V, McDonagh, E M, Chang, T, Caudle, K E, McLeod, H L, Haidar, C E, Klein, T, Luzzatto, L
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2014
Soggetti:
CPIC Guidelines
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4111801/
https://ncbi.nlm.nih.gov/pubmed/24787449
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/clpt.2014.97
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi